Inotiv | analyze. answer. advance.
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2023

Press Release

January 23, 2023

Inotiv, Inc. Announces Changes to Board of Directors

Press Release

January 10, 2023

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results

Press Release

January 4, 2023

Inotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023

Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2023 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH